EMIT Imaging’s flagship platform fully automates the CFT workflow: 3D visualisation of drug biodistribution and protein expression across whole organisms, at high resolution and high sensitivity.
Cryo-fluorescence tomography is an ex-vivo, volumetric tissue imaging technique: white-light images provide the anatomy, fluorescence shows the labelled compound, and both are reconstructed into a single whole-body 3D dataset. Xerra automates this workflow end to end, so preclinical teams can process samples in their own lab.
The specimen is prepared and frozen; no clearing or slide preparation is required.
Xerra images the sample layer by layer: white light for anatomy, fluorescence for the labelled compound.
The stack becomes a volumetric dataset showing biodistribution and protein expression in anatomical context.
Fields in which EMIT Imaging’s CFT technology is used today, from pharmacokinetics to therapy development.
Whole-body biodistribution of compounds and carriers, on- and off-target.
Tumour targeting and immune response visualised in anatomical context.
Tracking delivery and expression of gene and cell based therapeutics.
High-resolution fluorescence imaging of the intact CNS.
Distribution of ADCs from organ level down to fine structures.
We start with your research question and assess openly whether CFT is the right fit before you invest.
Quotation, delivery and coordination handled from Germany: one contact instead of overseas time zones.
We coordinate installation and onboarding with EMIT Imaging, so your team gets productive quickly.
One contact for service and support, long after the system is installed.
Whether you are evaluating a system for your lab or looking for a distribution partner in Europe, we reply personally and quickly.